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Abstract
Colorectal anastomotic leakage is a serious complica-
tion of colorectal surgery, leading to high morbidity 
and mortality rates. In recent decades, many strate-
gies aimed at lowering the incidence of anastomotic 
leakage have been examined. The focus of this review 
will be on mechanical aids protecting the colonic anas-
tomosis against leakage. A literature search was per-
formed using MEDLINE, EMBASE, and The Cochrane 
Collaborative library for all papers related to prevention 
of anastomotic leakage by placement of a device in 
the colon. Devices were categorised as decompression 
devices, intracolonic devices, and biodegradable devic-
es. A decompression device functions by keeping the 
anal sphincter open, thereby lowering the intraluminal 
pressure and lowering the pressure on the anastomo-
sis. Intracolonic devices do not prevent the formation 
of dehiscence. However, they prevent the faecal load 
from contacting the anastomotic site, thereby prevent-
ing leakage of faeces into the peritoneal cavity. Many 
attempts have been made to find a device that de-
creases the incidence of AL; however, to date, none of 
the devices have been widely accepted. 
© 2011 Baishideng. All rights reserved.
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INTRODUCTION
Colorectal anastomotic leakage (AL) is a serious compli-
cation after colorectal surgery and may lead to high mor-
bidity and mortality rates. The incidence of  AL varies 
between 2.5% and 20% and the aetiology is multifacto-
rial[1-5]. 
In recent decades, many strategies aimed at lower-
ing the incidence of  anastomotic leakage have been 
examined. A protective stoma reduces the consequence 
of  anastomotic failure, thereby preventing the number 
of  clinical leaks[6,7]. The Dutch TME trial demonstrated 
a lower rate of  surgical re-intervention in patients with 
a diverting stoma (P < 0.001)[2]. However, a protective 
stoma can also result in stoma-related complications, and 
the obligatory operation to take down the stoma is asso-
ciated with additional mortality, morbidity, and cost[8]. In 
addition, so-called temporary protective stomas tend to 
be left in situ for much longer than initially anticipated, 
sometimes even lifelong[9]. 
Many definitions are used to describe anastomotic 
leakage. The Surgical infection Study Group (1991) cat-
egorised AL into clinical and subclinical leakage[10]. In 
2001, Bruce et al[11] recommended the subdivision of  
anastomotic leakage into three groups: radiological (no 
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clinical signs), clinical minor (no intervention needed), 
and clinical major (intervention required) leakage. This 
grading of  AL resembles the grading of  AL proposed 
by the International Study Group of  Rectal Cancer (IS-
REC)[12]. The ISREC defines AL as a communication 
between the intra- and extraluminal compartments due 
to a defect of  the integrity of  the intestinal wall at the 
anastomosis between the colon and rectum or the colon 
and anus. The extent or severity of  AL should be graded 
according to the impact on clinical management. Grade 
A does not require active therapeutic intervention; grade 
B requires active therapeutic intervention, but is manage-
able without relaparotomy; and grade C requires relapa-
rotomy. 
In this review, we focus on the use and potential suc-
cess of  mechanical intraluminal devices that may protect 
a colonic anastomosis against leakage. Different strate-
gies have been adopted to lower the incidence of  AL. In 
this respect we will differentiate between transanal de-
compression, intracolonic, and biodegradable devices. In 
addition, devices encircling the bowel have been tested. 
The use of  some of  these devices showed promising re-
sults in lowering the incidence of  AL (Table 1). 
Considering the persisting associated morbidity and 
mortality of  AL, and availability of  intraluminal colonic 
devices today, a revival of  the discussion of  their effec-
tiveness in lowering the incidence of  AL is worthwhile. 
LITERATURE SEARCH
This is a retrospective review describing the literature 
on devices protecting colonic anastomoses. In March 
2010, an extensive literature search was performed us-
ing MEDLINE, EMBASE, and The Cochrane Col-
laborative Library for all papers related to prevention 
of  anastomotic leakage by placement of  an intraluminal 
device in the colon. Our search comprised the follow-
ing: (tube OR tubes OR bypass* OR by-pass OR stent* 
OR device* OR coloshield) AND (anastomosis OR 
anastomo*) AND (leak* OR dehiscen*) AND (colon 
OR rectum OR colonic OR intracolonic OR colorectal) 
AND (prevent* OR protect*). Articles were marked 
as relevant if  an intraluminal device was studied that 
protected a colonic anastomosis from leakage. Articles 
describing glues or fluids that protect the anastomosis 
are not included in this review, neither are studies on 
techniques of  anastomosing the bowel. The reference 
list of  each relevant article was checked for further rel-
evant papers. All first authors of  relevant papers were 
checked for other relevant publications. All articles were 
selected by one reviewer and in case of  doubt, a second 
reviewer was consulted. The Internet was also searched 
using www.scholar.google.com. The search yielded 337 
articles of  which 44 were related to an intraluminal de-
vice intended to protect a colonic anastomosis. These 44 
articles include experimental animal studies, as well as 
retrospective and prospective clinical studies. 
TRANSANAL DECOMPRESSION DEVICES 
A decompression device functions by keeping the anal 
sphincter open, thereby decreasing the intraluminal pres-
sure, as well as the pressure on the anastomosis. In this 
way, the device serves as a protective vent. In addition, a 
number of  authors have hypothesized that some tubes 
permit reinforcement and prevent angulation of  the 
bowel and anastomosis. As early as in the 13th century, 
Lanfrank reported the placement of  a reed pipe as an 
intraluminal stent in the colon[13]. More recently, Gurjar[14] 
assessed the current practice of  rectal tubes in the United 
Kingdom and Ireland. A questionnaire was sent to all 
members of  the Association of  Coloproctology (ACP-
GBI). The response rate was 58%, and 35% of  those re-
ported to use a rectal tube, in the majority of  cases after 
ileo-anal or colonic pouch surgery. Sixteen percent used 
the tube after low anterior resection (LAR). Predomi-
nantly, a Foley catheter was positioned above the anasto-
mosis (80%). The catheter was left in situ for a median of  
five days. Most respondents used the tube with the inten-
tion to decompress the rectum and/or pouch. 
Animal studies
In 1988, Goldman et al[15] tested an intrarectal, conically 
shaped flexible silastic tube in a dog model of  LAR. The 
tube was fixed to the submucosa 5 cm proximal to the 
anastomosis. Twenty-five dogs underwent an LAR; 15 
with a tube and 10 controls. In some animals, the anas-
tomosis was deliberately made incomplete, leaving gaps. 
Mortality occurred only in the control group. Morbidity 
in the control group was six times higher (three colocu-
taneous fistulae and three anastomotic abscesses). Only 
one dog with a tube and an incomplete anastomosis was 
diagnosed with a pelvic abscess. The tubal fixation sites 
showed oedema and minor inflammatory reaction on 
microscopic examination. The authors concluded that 
their procedure presented effective practical implica-
tions, such as omitting the need for a proximal protective 
colostomy.
Human studies
Indwelling rectal tubes: Stewart[16] used an indwelling 
rectal tube in 153 patients who underwent a left hemi-
colectomy or sigmoid resection. After completion of  the 
anastomosis, a No. 32-34 French latex tube was intro-
duced through the anal canal and directed through the 
anastomosis to a distance of  approximately 15 centim-
eters above the anastomosis. The rectal tube was sutured 
to the perianal skin for fixation. Twice daily, the tube 
was irrigated with neomycin solution and after five or six 
days, the tube was removed. Suture-line complications 
occurred in seven patients (4.6%), with three patients 
being graded as C according to the ISREC classification. 
In the other four patients, the anastomotic complica-
tions were grade A/B (haematoma, stricture, and abscess 
noted only on sigmoidoscopy). Adverse effects of  the 
tube (e.g., ulceration of  the colon) were not observed. 
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Table 1  Studies on intracolonic devices aimed at preventing anastomotic leakage
In 1978, Balz et al[18] reviewed a series of  392 patients 
undergoing anterior resection with placement of  an ind-
welling rectal tube. Anastomotic complications occurred 
in 3.8%. In addition to decompression, the rectal tube 
facilitated intraluminal antibiotic irrigation of  the anas-
tomosis.
Transanal rubber drain: In 2001, Sterk et al[19] used a 
transanal rubber drain to protect the anastomosis after 
low anterior resection in 50 patients. The maximal dis-
tance between the anastomosis and the anal skin was 
7 cm. The transanal rubber drain had openings on the 
side, a length of  40 cm, and a diameter of  12-15 mm. 
The tip of  the drain was positioned about 10 cm proxi-
mal to the anastomosis; the other end was fixed to the 
perineal skin. Two patients (4%) developed a grade C 
AL and three patients (6%) a grade A AL. The authors 
concluded that the transanal drain was at least equivalent 
to a conventional colostomy to reduce symptomatic AL. 
Human trials
Transanal stent: The transanal stent (TAS) is a radio-
opaque soft silicone tube, 4 cm in length with funnel-
shaped flanges. It is inserted into the anal canal at the end 
of  the procedure, and is left in situ for 5-7 d (Figure 1). 
Amin et al[20] performed a randomised trial with the TAS 
in LAR for rectal cancer. Forty-two of  118 patients were 
not randomised because of  high dose pre-operative ra-
diotherapy, concern about the anastomosis, or obstructing 
tumours. Seventy-six patients were randomised to TAS or 
a proximal defunctioning loop stoma (LS). No significant 
difference in AL rate was demonstrated between the two 
groups (TAS: three AL’s, all grade C; LS: two AL’s grade 
A and C). Patients with a TAS had fewer general infec-
tious complications (17% vs 35%) and a shorter hospital 
stay (13 vs 23 d; P < 0.001). This study is one of  the few 
trials that actually tested an intracolonic device. Unfortu-
nately, the randomisation strategy is not very clear and no 
control group with patients without an LS or TAS were 
described. 
In 2006, Bülow et al[21] performed a prospective ran-
domised trial to evaluate TAS in patients undergoing 
anterior resection for a mobile rectal tumour. The use 
of  a protective ileostomy was left to the discretion of  
the operating surgeon. After completion of  the opera-
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Study[Ref.] Yr n Site Device Anastomotic complications
Rack[17] 1966   32 Sigmoid or rectum resection Rectal tube 0 AL
Stewart et al[16] 1968 153 Left colon or colorectal resection Rectal tube 4 Grade A/B AL (3%)
3 Grade C AL (2%)
Balz et al[18] 1978 392 (including 153 patients 
from study Stewart)
Left colon or colorectal resection Rectal tube 3 Grade A/B AL (1%)
6 Grade C AL (2%)
Castrini et al[33] 1984   19 Left colon or rectal resection Intracolonic bypass 0 AL
Ravo et al[35] 1987   28 Sigmoid resection Intracolonic bypass 0 AL
Cuilleret et al[53] 1991   14 Left colon resection Intracolonic bypass 0 AL 
Ravo et al[34] 1985   29 Left colon or rectal resection Intracolinic bypass 0 AL
Ravo[29] 1988 Case report Sigmoid resection Intracolonic bypass 0 AL
Keane et al[37] 1988     6 Sigmoid or rectal resection Intracolinic bypass 0 AL
Rosati et al[36] 1992   29 Left colon or rectal resection Intracolinic bypass 2 AL (7%)
Egozi et al[38] 1993 Case report Sigmoid Intracolinic bypass Colon necrosis at site of tube
Yoon et al[41] 1994   10 LAR Condom 0 AL
Sterk et al[19] 2001   50 LAR Transanal tube 3 Grade A AL (6%)
2 Grade C AL (4%)
Amin1 et al[20] 2003   76 LAR 41 transanal stent Stent: 3 Grade C AL (7%)
35 loop stoma Stoma: 1 Grade A AL (3%)
1 Grade C AL (3%)
Bülow2 et al[21] 2006 194 LAR 98 Transanal stent Stent: 17 AL (17%)
96 controls Control: 8 AL (8%)
Ye3 et al[47] 2008   83 LAR 44 VIB VIB: 2 Grade A AL (5%)
39 Loop ileostomy Stoma: 2 Grade A AL (5%)
Kolkert et al[48] 2010   15 Sigmoid or rectal resection C-seal 0 AL
1Randomized trial; 2Randomized trial, with/without stent and with/without ostomy; 3Patient could choose between VIB and LI. AL:Anastomotic leakage, 
according to the ISREC classification[12]; LAR: Low anterior resection; VIB: Valtrac-secured intracolonic bypass; LI: Loop ileostomy; ISREC: International 
Study Group of Rectal Cancer.
Figure 1  Transanal stent. 
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tion, patients were randomised to the TAS group or the 
control group. After inclusion of  194 patients (of  the 
planned 448 patients) an interim analysis was performed 
because of  the occurrence of  several leaks over a short 
time. Clinically significant leakage was diagnosed in 25 
patients (13%), of  whom seven were treated with drain-
age only and 18 with relaparotomy. AL occurred more 
frequently in the TAS groups (17%) than in the control 
group (8%). Although the difference in leak rate appears 
to be clinically relevant, the difference was not statistical-
ly significant because of  the small sample size (P = 0.09). 
The study was stopped prematurely for ethical reasons 
because of  this trend. Although this study was unable to 
demonstrate a statistical difference in AL between the 
groups, it seems unlikely that inserting the TAS reduces 
the incidence of  AL (Figure 1).
INTRALUMINAL DEVICES
Intracolonic devices do not aim at preventing anasto-
motic dehiscence. However, they may prevent the faecal 
load from contacting the anastomotic site, thereby pre-
venting leakage of  faeces into the peritoneal cavity when 
the walls of  the anastomosis have become dehiscent. 
When the faecal stream is bypassed from contacting the 
bowel mucosa, a gap in the anastomosis will not lead 
to extravasation of  intraluminal content. Shielding the 
anastomosis from contact with faeces might also reduce 
the incidence of  AL[22].
Animal studies
Coloshield: In the 1980’s, Ravo and Ger developed an 
intraluminal colonic tube to prevent anastomotic leakage. 
The application procedure is illustrated in Figure 2. After 
the bowel resection, the proximal loop is inverted for 4-6 
centimetres. The proximal end of  the tube, reinforced 
with a cloth strip, is fixed to the proximal bowel loop 
using polyglycolic acid sutures. The inverted intestinal 
portion is overturned to its normal anatomic position 
and the posterior half  of  the anastomosis is performed. 
Then, a rectal probe is introduced through the anus and 
is connected to the tube by a built-in connector. The 
probe is drawn outside the intestinal lumen through the 
distal bowel and the anastomosis is completed by sutur-
ing the anterior part. The tube is then cut at the level 
of  the anal orifice after a light traction, spontaneously 
returning inside. In cases where the mid-or lower rectum 
is resected, the tube is left protruding from the anus and 
an incontinence bag is attached to the perineum[23]. Stud-
ies on dogs were performed using different tubes vary-
ing in width and length, material (latex, silicone, rubber), 
and suture technique. The colon tube placement was 
found to be a safe, uncomplicated procedure and none 
of  the dogs (three studies, 14 dogs per study) developed 
AL (evaluated by laparotomy and barium studies). All 
tubes were expelled naturally together with the faecal 
stream[24-26]. Even when an intentionally incomplete anas-
tomosis was made after inserting the tube, no AL oc-
curred. In 1985, the bypass tube was successfully tested 
on five dogs using a (circular) stapler[27]. 
Silicone prosthesis: In 1992, Serra et al[28] studied the ef-
ficacy of  intracolonic silicone prosthesis in 42 dogs. The 
use of  the prosthesis is similar to the technique described 
by Ravo and Ger[23,26,29]. The primary objective of  the 
study was to evaluate the efficacy of  the intracolonic 
silicone prosthesis in protecting the anastomosis. Three 
groups of  14 dogs each (colonic occlusion, diverticulitis, 
and control) were randomized to undergo resection and 
anastomosis with or without the silicone prosthesis. A 
significant difference in mortality was found: six dogs 
without prosthesis developed anastomotic failure, of  
which three died. No deaths or AL occurred in the pros-
thesis groups.
Soft latex tube: Intraluminal colonic tubes were studied 
by Ross[30] in a rat model. The rats were divided in four 
groups; all underwent colon diversion with creation of  
an incomplete anastomosis. The first group consisted 
of  rats treated with an intracolonic tube made from rat 
duodenum. In the second group, an intracolonic soft 
latex tube was introduced. The third group had a tube 
placed outside the colon lumen, and the last group was 
a control group with an incomplete anastomosis. The 
tubes were attached 1.5 cm above the incomplete anas-
tomosis. The tubes remained inside the rectum, barely 
reaching the dentate line and were removed after five or 
six days. Rats treated with latex and rat duodenum tubes 
showed a better survival compared to controls (52% and 
71%, respectively vs 25% in controls). Rats treated with 
rat duodenum showed a significant better survival com-
pared to the control group (P < 0.02). A mortality rate 
of  100% was found in rats with a tube placed outside 
the lumen of  the colon. The results suggest that only 
intraluminal tubes have a survival advantage compared 
to controls. This finding may be explained by the fact 
that tubes will prevent faecal contamination of  the anas-
tomotic site and allow time for secondary healing of  the 
anastomosis. 
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Anus
Coloshield
Figure 2  The Coloshield. A: The coloshield is sutured to the submucosa of 
the bowel proximal of the anastomosis; B and C: Slight traction is placed on the 
coloshield and it is cut so that it lies in the rectal ampulla. 
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Polyflex self-expandable covered plastic stent: As a 
result of  achievements in biomedical technology, in 2008 
Tsereteli et al[31] performed a randomized controlled trial 
in 16 pigs comparing the incidence of  AL after open 
rectosigmoid resection with or without a 21 mm Poly-
flex self-expandable covered plastic stent (Figure 3). The 
stent was placed over a guidewire with use of  a flexible 
colonoscope and deployed under fluorescence control. 
A 2-cm anastomotic gap was created. After 6-9 d, stents 
were spontaneous expelled. At autopsy, none of  the 
animals in the study group (n = 8) showed leak-related 
complications, although two pigs developed an unrelated 
postoperative complication (evisceration and bladder 
necrosis) and died. Five out of  eight control animals (63%) 
showed intra-abdominal infection around the anastomo-
sis at autopsy, with four abscesses and one fistula. This 
demonstrated a significant beneficial effect of  the stent 
group vs controls (P = 0.002). The authors stated that the 
stent could be a breakthrough solution for the compli-
cated colorectal anastomosis, avoiding the necessity of  a 
stoma during the healing process. A potential new indica-
tion for this stent was also to seal an acute anastomotic 
leak, which is supported by one case report describing 
the successful use of  a coated stent in healing a 1-cm 
fistula from a rectosigmoid anastomosis two weeks after 
surgery[32] 
Human studies
Coloshield: The development of  the intraluminal tube 
led to the final version of  the Coloshield: a soft, pliable 
tube like a surgical glove. This intraluminal protective 
device, developed by Ravo, was first used in humans in 
1984[25,33]. Indications for use include perforated diver-
ticulitis, colonic obstruction, volvulus, carcinoma, and 
fistula. Several non-randomized studies were performed 
in patients (ranging from n = 6 to n = 98) undergoing 
colon surgery with the Coloshield. The reported anas-
tomosis-related complication rates varied between 0% 
and 8.7%[23,25,34-37]. The Coloshield related complications 
included two anastomotic dehiscences (from a group of  
98 patients) following low anterior resection, both at-
tributed to technical errors[23]. Egozi et al[38] described a 
case with a complicated course after insertion of  a rigid 
intracolonic bypass. On the 8th postoperative day, the 
Coloshield was found to have eroded through the colon. 
Castrini et al[33] tested an intracolonic latex bypass in 19 
patients undergoing left colon or rectal resection. None 
of  these patients developed anastomotic complications. 
Regrettably, no detailed information concerning proce-
dures, patients, and complications was reported.
The last article concerning the Coloshield was pub-
lished by Ravo in 1991. Ravo described a method of  
inserting the Coloshield in the proximal colon after com-
pletion of  the anastomosis by performing a longitudinal 
colostomy on the antimesenteric border of  the afferent 
loop, proximal to the anastomosis[39]. Ravo and Ger pio-
neered the use of  intracolonic stents, testing different 
materials (silicone, rubber, and latex) before developing 
and, finally, filing the patent of  the latex Coloshield[40]. 
They concluded that the one-stage intracolonic bypass 
procedure is a viable alternative to the two- or three-
stage procedure because it reduces the length of  hospital 
stay and the length of  disability. Despite its promise, the 
Coloshield has not been widely accepted. Ravo still uses 
the Coloshield (personal communication). 
Condom: In 1994, Yoon et al[41] used a condom instead of  
a Coloshield to protect the colo-anal anastomosis. Ten 
patients with rectal carcinoma undergoing LAR received 
this condom. The ring of  the sterilised condom was 
sutured to the mucosal and submucosal layer of  the 
proximal colon before completing the anastomosis. The 
condom was brought to the exterior and transected with 
scissors. The device is expelled naturally from the anus 
between the 10th and 14th postoperative day. No anasto-
motic dehiscence, leakage, or colonic necrosis occurred. 
In 1995, Ruiz et al[42] described the same method using a 
condom (termed a skinless skin) as a protective device 
in a colonic anastomosis. When using a stapler, the distal 
end of  the condom is attached to the anvil of  the EEA 
stapler with two stay sutures, permitting it to be pulled 
through the anastomosis. Ruiz et al hypothesized that a 
latex condom is a cheap and safe device that decreases 
the risk of  dehiscence and permits the performance of  a 
large number of  primary anastomoses. Unfortunately, for 
both studies, no detailed information on the procedures 
and patients are available.
BIODEGRADABLE DEVICES
Animal studies
In 1993, Winkeltau tested the protective effect of  biode-
gradable bipolymer intraluminal stents in 90 rats under 
the adverse condition of  induced general peritonitis 
(verified by inspection, microbiology, and histology)[43]. 
Peritonitis was induced using the cecal ligation and punc-
ture model[44]. Stents of  various shapes and biodegrad-
able materials were compared to controls with no stents, 
in rats undergoing jejuno-jejunostomy. The survival 
rate in the control group was 25% and rats receiving a 
tube had a significantly better survival, varying between 
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Figure 3  Polyflex stents with a proximal flare. 
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65% and 90%. The best results were obtained in rats 
with a funnel shaped BCL-004 tube, mainly composed 
of  polyhydroxybutyric acid (PHB). The use of  degrad-
able materials is not restricted to the distal parts of  the 
gastrointestinal tract, since it does not carry the risk of  
causing an obstruction. 
Valtrac secured intracolonic bypass (VIB): Chen[45] 
introduced the VIB, which consists of  a soft vinyl tube at-
tached to a biofragmentable anastomosis ring (BAR). The 
BAR was introduced by Hardy et al[46] in 1985 (inspired by 
Murphy’s button). The BAR realises a sutureless intestinal 
anastomosis composed of  two identical segments. The 
two components interdigitate and can be approximated to 
a semi-closed position with a 6 mm gap between the two 
edges of  the ring (Figures 4 and 5).
Chen attached the BAR to the lumen of  a pig’s co-
lon, 5-10 cm proximal from the anastomotic site, by 
putting a simple suture encircling the colon at the site 
of  the BAR gap. The tube attached to the BAR passed 
through the anastomosis to the anus, thereby prevent-
ing contact between the anastomotic site and the faecal 
stream. Eighteen pigs underwent colonic resection with 
the deliberate creation of  an incomplete anastomosis. Six 
pigs received the bypass, six received the bypass under 
the condition of  a colonic outlet obstruction (created by 
tying a purse string suture at the level of  the anus) and 
six pigs were controls. All pigs with the bypass had no 
anastomotic leakage (checked by a barium enema) and 
survived. Temporary anorexia and abdominal distension 
were noted in pigs with a colonic outlet obstruction. 
Four of  six controls developed anastomotic leakage, of  
which three died. 
Human studies
Valtrac secured intracolonic bypass: In 2002, the VIB 
was tested on 83 patients undergoing LAR for rectal can-
cer[47]. After inclusion, the patient decided whether he/
she wanted to be treated with the VIB or with a loop ile-
ostomy (LI) to protect the anastomosis. The VIB was at-
tached to the colon 5-7 cm proximal of  the anastomosis 
by the same method Chen et al used in their experimental 
study. The fragmentation and excretion of  the BAR oc-
curred 12-22 d postoperatively. Fifty-three percent of  
patients chose the VIB and 47% chose the LI as treat-
ment. Four subclinical anastomotic dehiscences were di-
agnosed, two in each group. Total hospital stay and costs 
were significant lower in the VIB group (P = 0.001); no 
readmission for a take down of  the stoma was indicated. 
In two patients, the BAR detached en-bloc, which led to 
a difficult expulsion. In these cases the BAR was manu-
ally crushed and excreted through the anus. The authors 
concluded that the VIB is a safe and effective diverting 
technique to protect an elective low colorectal anastomo-
sis; it avoids stoma-related complications and lowers the 
cost. This study can be criticized because the lack of  ran-
domization and high probability of  introduction of  bias. 
C-seal: A recent development from the Groningen group 
is the C-seal: a thin walled tube like a soft sheet or con-
dom, with a diameter of  4 cm, a length of  25 cm and a 
wall thickness of  70 µm (Figure 6). The C-seal is a tubu-
lar device composed of  a biodegradable synthetic mate-
rial. Two flaps with adhesive tape are located at one end 
of  the tube. These flaps are used to attach the C-seal to 
the stapler cap, to facilitate an easy pull-through of  the 
C-seal after the anastomosis is made (http://www.jove.
com/index/details.stp?ID=2223). The C-seal remains 
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Figure 4  Murphy’s button. John Benjamin Murphy developed his device in 
1892 as a quick and safe method of intestinal anastomosis. The steel Murphy 
button had two rounded heads mounted on hollow shafts. After the intestinal 




Figure 5  Valtrac-secured intracolonic bypass device. A: Rough colorectal 
anastomosis with large gaps between sutures protected by the intracolonic by-
pass; B: Biofragmentable anastomosis ring. 
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in place for about 10 d, according to the engineered 
composition of  the biodegradable material. Thereafter, 
it looses strength, degrades, and is secreted from the 
body together with the gastrointestinal natural contents. 
In 2007, a pilot study was performed testing the C-seal 
in 15 patients diagnosed with colorectal carcinoma un-
dergoing LAR with stapled anastomoses[48]. No (sub) 
clinical AL was diagnosed in these 15 patients. Currently, 
the C-seal is being tested in a second phase study of  35 
patients undergoing (colo-)rectal resection with stapled 
colorectal anastomosis. 
CONCLUSION
The relative high incidence of  anastomotic leakage af-
ter colorectal surgery, with its major consequences for 
morbidity and mortality, remain of  great concern. Some 
authors concentrate on early detection of  anastomotic 
dehiscence to reduce the consequences of  AL[49-52]. The 
ideal situation, however, would be prevention of  anas-
tomotic leakage. Many devices have been developed to 
prevent AL by protecting the anastomotic site. We cat-
egorised these devices as transanal decompression, intra-
luminal, and biodegradable protective devices. A number 
of  studies concerning intraluminal tubes demonstrate 
low leakage rates[18,33-35,48]. Despite these positive results, 
the use of  protective devices has not been widely imple-
mented. Clinicians are probably reluctant to use these 
devices in clinical practice for a number of  reasons. 
First, the use of  intraluminal devices has only a small 
basis of  evidence in the literature. Most papers are either 
animal studies or small, non-randomized human studies, 
often without a control group. Furthermore, most stud-
ies are heterogeneous and use different devices[33,37,41,53]. 
Only two randomized, controlled studies are published, 
both on decompression devices. Amin et al[20] compared 
a defunctioning stoma with the transanal stent. This 
study does not show a benefit of  the transanal stent. 
The study suffers from unclear eligibility criteria and a 
non-transparent randomisation process: one-third of  
the registered patients were not randomised. With 76 
evaluable patients, the study is not sufficiently powered 
to detect significant differences in leakage rate between 
the groups. A similar study by Bülow[21] was prematurely 
stopped due to a high overall leakage rate, with a trend 
for a higher leakage rate in the TAS group. 
Contrary to the transanal stent, a number of  papers 
suggest that the Coloshield may help to reduce AL, 
though this beneficial effect has only been demonstrated 
in small studies with no control group[33-35,39,41,53]. Unfor-
tunately, no proper, randomised trial comparing the Co-
loshield to the standard of  care has been performed until 
now. 
Another aspect of  the Coloshield is that it is consid-
ered time-consuming and tedious to apply, making it less 
attractive than the standard procedure. Tsereteli hypoth-
esized that the Coloshield never found wide acceptance 
because of  its technical difficulties and the requirement 
of  a laparotomy for placement[31]. Finally, medical devic-
es are often only successfully introduced by companies 
who can organize an optimal marketing campaign and 
a widespread network of  representatives. According to 
Ravo, the Coloshield was never widely accepted because 
it lacked these factors. Nevertheless, Ravo still uses the 
Coloshield in daily practice (personal communication).
We conclude that there is currently no high-level evi-
dence demonstrating a benefit of  intraluminal devices 
to reduce AL. Based on the literature, we think that the 
intraluminal device holds clinical promise to reduce or 
prevent early leakage of  colo-rectal anastomoses and 
concomitant sequelae (Table 1). Although a number of  
very innovative approaches have been reported, not all 
devices have been appropriately studied in a randomized, 
controlled fashion with sufficient power to rule out 
chance or bias. 
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